Latest Breaking News On - Jefferie yee - Page 2 : comparemela.com
Sales of Alzheimer s Drug Leqembi May Be Slow Initially But Could Pick Up in 2024
nbcsandiego.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcsandiego.com Daily Mail and Mail on Sunday newspapers.
Deals surge, returns slip: takeaways from a record half for biotech IPOs
biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.
May 24, 2021
Biotechnology equities are slumping to start 2021, with the S&P Biotechnology Select Industry Index down 10% year-to-date.
Mergers and acquisitions activity, which are typically vibrant in the biotech space, are also in a funk. Yet many experts believe biotech consolidation is poised to pick up the pace in the second half of 2021. If that happens, the
SBIO components have market values of $200 million to $5 billion at the time of inclusion in the fund. Even the higher end of that range is a sweet spot for cash-rich pharmaceuticals companies looking to replenish drug pipelines and fend off patent cliffs. With the aforementioned decline by the S&P Biotechnology Select Industry Index, some pharmaceuticals could now be on the prowl for takeover targets.